- Home
- DAWN vs CGNT Comparison
DAWN vs CGNT Comparison
Compare DAWN & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- CGNT
- Stock Information
- Founded
- DAWN 2018
- CGNT 2020
- Country
- DAWN United States
- CGNT Israel
- Employees
- DAWN N/A
- CGNT N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- CGNT Computer Software: Prepackaged Software
- Sector
- DAWN Health Care
- CGNT Technology
- Exchange
- DAWN Nasdaq
- CGNT Nasdaq
- Market Cap
- DAWN 624.8M
- CGNT 617.3M
- IPO Year
- DAWN 2021
- CGNT N/A
- Fundamental
- Price
- DAWN $9.14
- CGNT $8.55
- Analyst Decision
- DAWN Strong Buy
- CGNT Buy
- Analyst Count
- DAWN 8
- CGNT 2
- Target Price
- DAWN $27.63
- CGNT $14.00
- AVG Volume (30 Days)
- DAWN 1.9M
- CGNT 289.4K
- Earning Date
- DAWN 11-04-2025
- CGNT 12-10-2025
- Dividend Yield
- DAWN N/A
- CGNT N/A
- EPS Growth
- DAWN N/A
- CGNT N/A
- EPS
- DAWN N/A
- CGNT N/A
- Revenue
- DAWN $133,672,000.00
- CGNT $376,566,000.00
- Revenue This Year
- DAWN $12.88
- CGNT $15.30
- Revenue Next Year
- DAWN $48.27
- CGNT $11.30
- P/E Ratio
- DAWN N/A
- CGNT N/A
- Revenue Growth
- DAWN 31.11
- CGNT 14.04
- 52 Week Low
- DAWN $5.64
- CGNT $6.45
- 52 Week High
- DAWN $16.76
- CGNT $11.66
- Technical
- Relative Strength Index (RSI)
- DAWN 71.77
- CGNT 53.42
- Support Level
- DAWN $7.11
- CGNT $8.24
- Resistance Level
- DAWN $7.62
- CGNT $8.99
- Average True Range (ATR)
- DAWN 0.47
- CGNT 0.23
- MACD
- DAWN 0.10
- CGNT 0.05
- Stochastic Oscillator
- DAWN 72.26
- CGNT 62.66
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.